These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7614064)

  • 21. Vaccination against hepatitis A and B: developments, deployment and delusions.
    Zuckerman JN
    Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
    Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
    Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
    Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
    Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccination against Hepatitis B: 20 years later].
    Vildozola H
    Rev Gastroenterol Peru; 2007; 27(1):57-66. PubMed ID: 17431429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for prevention and control of hepatitis B and hepatocellular carcinoma.
    Sobeslavsky O
    IARC Sci Publ; 1984; (63):271-8. PubMed ID: 6100274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Seroepidemiological study and program of vaccination against hepatitis B in school children in Extremadura].
    Gimeno Ortiz A; Jiménez Romano R; Zarallo Barbosa T
    Rev Sanid Hig Publica (Madr); 1993; 67(5):369-76. PubMed ID: 7732304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Practical considerations of immunoprophylaxis in viral hepatitis].
    Nemesánszky E; Csepregi A
    Orv Hetil; 1998 Aug; 139(31):1835-42. PubMed ID: 9729677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Viral hepatitis and immunoprophylaxis].
    Deinhardt F; Jilg W
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):134-45. PubMed ID: 2986380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
    Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
    Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of immunization against hepatitis A.
    Lemon SM; Shapiro CN
    Infect Agents Dis; 1994 Feb; 3(1):38-49. PubMed ID: 7952926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.
    Rots NY; Wijmenga-Monsuur AJ; Luytjes W; Kaaijk P; de Graaf TW; van der Zeijst BA; Boog CJ
    Vaccine; 2010 Jan; 28(4):893-900. PubMed ID: 19932217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined vaccine against hepatitis A and B].
    Pawłowska M; Halota W; Kozielewicz D
    Przegl Epidemiol; 2004; 58 Suppl 1():66-70. PubMed ID: 15807160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis vaccination among drug users.
    Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A
    Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.